• Company
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Open Science Fellows
  • Scientific Paradigm
    • Physics-Driven Platform
      • Quantum Mechanics
      • Thermodynamics
      • Molecular Simulation
      • Supercomputing Infrastructure
    • Drug Design
      • Multidisciplinary Team
      • Integrated Approach
      • Conformational Genetics
    • Scientific Publications
      • All Scientific Publications
  • Therapeutics and Pipeline
    • STING Agonist
    • ADAR 1 Antagonist
    • WRN Antagonist
    • Vaccine Adjuvant Platform
  • News
    • Press Releases
    • Events
  • Careers
    • Values
    • Culture
    • Open Positions
  • Contact
Silicon Therapeutics Logo
  • Company
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Open Science Fellows
  • Scientific Paradigm
    • Physics-Driven Platform
      • Quantum Mechanics
      • Thermodynamics
      • Molecular Simulation
      • Supercomputing Infrastructure
    • Drug Design
      • Multidisciplinary Team
      • Integrated Approach
      • Conformational Genetics
    • Scientific Publications
      • All Scientific Publications
  • Therapeutics and Pipeline
    • STING Agonist
    • ADAR 1 Antagonist
    • WRN Antagonist
    • Vaccine Adjuvant Platform
  • News
    • Press Releases
    • Events
  • Careers
    • Values
    • Culture
    • Open Positions
  • Contact
  News  Press Releases  Silicon Therapeutics Has Raised Over $50…

Silicon Therapeutics Has Raised Over $50mil to Date and Counts the BIDMC, Sequoia, Chengwei, and its Employees as its Major Stakeholders

Mar. 25, 2019

Additional Information forthcoming.

Share this:

  • Twitter
  • Facebook
  • Company
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Open Science Fellows
  • Scientific Paradigm
    • Physics-Driven Platform
      • Quantum Mechanics
      • Thermodynamics
      • Molecular Simulation
      • Supercomputing Infrastructure
    • Drug Design
      • Multidisciplinary Team
      • Integrated Approach
      • Conformational Genetics
    • Scientific Publications
      • All Scientific Publications
  • Therapeutics and Pipeline
    • STING Agonist
    • ADAR 1 Antagonist
    • WRN Antagonist
    • Vaccine Adjuvant Platform
  • News
    • Press Releases
    • Events
  • Careers
    • Values
    • Culture
    • Open Positions
  • Contact
Silicon Therapeutics Expands Board by Na
Silicon Therapeutics Announces Prof. Dav
Gemini Therapeutics Logo
  • Contact
  • Privacy Policy
  • Terms of Use

Follow:

  • Linkedin
  • Twitter
  • Youtube
© 2021 Silicon Therapeutics